These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23110068)

  • 21. Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks.
    Rose R; Rodriguez C; Dollar JJ; Lamers SL; Massaccesi G; Osburn W; Ray SC; Thomas DL; Cox AL; Laeyendecker O
    Infect Genet Evol; 2019 Jul; 71():1-6. PubMed ID: 30802530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited overlap between phylogenetic HIV and hepatitis C virus clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM.
    Vanhommerig JW; Bezemer D; Molenkamp R; Van Sighem AI; Smit C; Arends JE; Lauw FN; Brinkman K; Rijnders BJ; Newsum AM; Bruisten SM; Prins M; Van Der Meer JT; Van De Laar TJ; Schinkel J;
    AIDS; 2017 Sep; 31(15):2147-2158. PubMed ID: 28692530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
    Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
    J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.
    Tully DC; Hahn JA; Bean DJ; Evans JL; Morris MD; Page K; Allen TM
    Clin Infect Dis; 2022 Mar; 74(6):993-1003. PubMed ID: 34448809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors.
    Brewer DD; Hagan H; Sullivan DG; Muth SQ; Hough ES; Feuerborn NA; Gretch DR
    J Infect Dis; 2006 Sep; 194(6):764-72. PubMed ID: 16941342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
    Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
    Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s.
    Freeman AJ; Zekry A; Whybin LR; Harvey CE; van Beek IA; de Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G; Lloyd AR
    Med J Aust; 2000 Jun; 172(12):588-91. PubMed ID: 10914104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men.
    Mahony AA; Donnan EJ; Lester RA; Doyle JS; Knox J; Tracy SL; Bowden S; Sasadeusz JJ
    Med J Aust; 2013 Mar; 198(4):210-4. PubMed ID: 23451966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.
    Bowden S; McCaw R; White PA; Crofts N; Aitken CK
    J Viral Hepat; 2005 May; 12(3):322-4. PubMed ID: 15850474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies.
    Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FM; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J
    J Viral Hepat; 2017 May; 24(5):404-411. PubMed ID: 27882678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
    Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users.
    Kato H; Maeno Y; Seko-Nakamura Y; Monma-Ohtaki J; Sugiura S; Takahashi K; Zhe LX; Matsumoto T; Kurvanov F; Mizokami M; Nagao M
    Forensic Sci Int; 2007 May; 168(1):27-33. PubMed ID: 16829004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012.
    Bretaña NA; Boelen L; Bull R; Teutsch S; White PA; Lloyd AR; Luciani F;
    Emerg Infect Dis; 2015 May; 21(5):765-74. PubMed ID: 25897788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs.
    Pilon R; Leonard L; Kim J; Vallee D; De Rubeis E; Jolly AM; Wylie J; Pelude L; Sandstrom P
    PLoS One; 2011; 6(7):e22245. PubMed ID: 21799802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
    Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
    J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.
    Palmateer N; Hutchinson S; McAllister G; Munro A; Cameron S; Goldberg D; Taylor A
    J Viral Hepat; 2014 Jan; 21(1):25-32. PubMed ID: 24329854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan.
    Hoshino K; Sugiyama M; Date T; Maruwaka S; Arakaki S; Shibata D; Maeshiro T; Hokama A; Sakugawa H; Kanto T; Fujita J; Mizokami M
    J Viral Hepat; 2018 Aug; 25(8):976-985. PubMed ID: 29577516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis.
    May S; Ngui SL; Collins S; Lattimore S; Ramsay M; Tedder RS; Ijaz S
    J Clin Virol; 2015 Mar; 64():6-11. PubMed ID: 25728071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
    J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India.
    Gupta D; Saha K; Biswas A; Firdaus R; Ghosh M; Sadhukhan PC
    Infect Genet Evol; 2017 Mar; 48():156-163. PubMed ID: 27923769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.